Publisher
Springer International Publishing
Reference99 articles.
1. Stange J, Stiffel M, Goetze A, Strube S, Gruenert J, Klammt S, Mitzner S, Koball S, Liebe S, Reisinger E. Industrial stabilizers caprylate and N-acetyltryptophanate reduce efficacy of albumin in liver patients. Liver Transpl. 2011;17(6):1–10.
2. Stange J, Koball S, Klammt S, Mitzner S, Hinz M, Weiss-Reining H, Reisinger E. Charcoal filtered albumin dialysis can reduce patients serum caprylate and improve albumin function and hemodynamics. Blood Purif. 2010;30:242.
3. Klammt S, Mitzner S, Stange J, et al. Albumin binding function is reduced in patients with decompensated cirrhosis and correlates inversely with severity of liver disease assessed by model for end-stage liver disease. Eur J Gastroenterol Hepatol. 2007;19:257–63.
4. Klammt S, Mitzner S, Stange J, et al. Improvement of albumin binding capacity is associated with improved survival in patients with decompensated liver cirrhosis. Liver Transpl. 2008;14:1333–9.
5. Dominik A, Stange J, Baumann AK, Pfensig C, Suraj M, Ibrahim B, Eggert M. Targeting albumin binding function as a therapy goal in liver failure: development of a novel adsorbent for albumin dialysis. Ther Apher Dial. 2018;22:196–204.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献